Mazar Andrew Paul 4
4 · ACTUATE THERAPEUTICS, INC. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Mazar Andrew Paul
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-04-01+51,046→ 51,046 totalExercise: $6.70Exp: 2035-03-31→ Common Stock (51,046 underlying) - Award
Employee Stock Option (right to buy)
2025-04-01+110,346→ 110,346 totalExercise: $6.70Exp: 2035-03-31→ Common Stock (110,346 underlying)
Footnotes (2)
- [F1]Options will vest as to 25% on April 1, 2026 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date.
- [F2]Options will vest as to 25% on August 14, 2025 with the remaining 75% vesting in equal monthly installments during the 36 months thereafter.